'That would have been the perfect thing after diagnosis': development of a digital lifestyle management application in multiple sclerosis.

"Competing interests: The authors declared the following potential conflicts of interest with respect to the research, authorship, and/or publication of this article: CH has received research grants, speaker honoraria, and travel grants from Biogen, Celgene, Genzyme, Merck, and Roche. JP has received research grants, speaker honoraria, and travel grants from Bayer, Celgene, and Merck. BM and FT are employed by GAIA, the company that developed, owns, and operates levidex. NK, KR-L, ACR, SK, HT, and MvdL have nothing to declare."

"Funding: The authors disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This study was publicly funded by the Innovationsfonds, Innovationsausschuss beim Gemeinsamen Bundesausschuss, Wegelystraße 8, 10623 Berlin, Germany (grant no. 01VSF17015). The funding body was not involved in any study-related aspect."